ABBV vs GTLS · P/E 81, rev $16.99B vs rev $4.16B
AbbVie Inc (ABBV) versus Chart Industries Inc (GTLS) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Chart Industries Inc (GTLS) is a specialty industrial machinery company listed on NYSE.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported GTLS revenue for 2024-12-31 was $4.16B. Net income was $232.8M. Revenue was up 24.1% from 2023-12-31 to 2024-12-31. GTLS currently screens at market cap $9.90B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. GTLS currently screens at market cap $9.90B.
Not investment advice. Open the ABBV and GTLS stock pages for the full models.
Not investment advice.